Ker Yu
Impact in
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer
- Peroxisome Proliferator-Activated Receptors
- Protein Kinase Regulation and GTPase Signaling
- Metabolism, Diabetes, and Cancer
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 46
- Protein Kinase Regulation and GTPase Signaling 12
- Polyamine Metabolism and Applications 6
- RNA Research and Splicing 5
- Immunology 17
- Mast cells and histamine 6
- Co-authors
- Robert T. Abraham (12 shared papers)Lourdes Toral‐Barza (25 shared papers)James J. Gibbons (14 shared papers)Judy Lucas (21 shared papers)Arie Zask (21 shared papers)Boris Shor (6 shared papers)Semiramis Ayral‐Kaloustian (19 shared papers)Irwin Hollander (20 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (14 papers)Journal of Medicinal Chemistry (11 papers)Acta Pharmacologica Sinica (5 papers)Oncogene (3 papers)Oncotarget (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Ker Yu
84 papers receiving 4.6k citations
Ker Yu's Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 3.3k
- Cancer Research 536
- Organic Chemistry 800
- Genetics 262
- Toxicology 84
Countries citing papers authored by Ker Yu
This map shows the geographic impact of Ker Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ker Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ker Yu more than expected).
Fields of papers citing papers by Ker Yu
This network shows the impact of papers produced by Ker Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ker Yu. The network helps show where Ker Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ker Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids Hit paper breakdown → | 1995 | 625 |
| 2 | 2001 | 368 | |
| 3 | 2009 | 285 | |
| 4 | 2010 | 276 | |
| 5 | 2010 | 192 | |
| 6 | 2009 | 173 | |
| 7 | 2010 | 171 | |
| 8 | 2010 | 152 | |
| 9 | 2009 | 136 | |
| 10 | 2008 | 106 | |
| 11 | 2009 | 94 | |
| 12 | 2009 | 83 | |
| 13 | 2008 | 73 | |
| 14 | 2009 | 69 | |
| 15 | 2009 | 67 | |
| 16 | 2010 | 63 | |
| 17 | 2010 | 61 | |
| 18 | 2005 | 58 | |
| 19 | 2007 | 56 | |
| 20 | 1992 | 51 |
About Ker Yu
Ker Yu is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Oncology and Pharmacology, having authored 86 papers that have together received 4.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (46 papers), Protein Kinase Regulation and GTPase Signaling (12 papers), Mast cells and histamine (6 papers), Polyamine Metabolism and Applications (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Fungal Plant Pathogen Control (6 papers), RNA Research and Splicing (5 papers) and Quinazolinone synthesis and applications (5 papers). The work is most often cited by research in Molecular Biology (3.3k citations), Cancer Research (536 citations), Organic Chemistry (800 citations), Genetics (262 citations) and Toxicology (84 citations). Ker Yu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Robert T. Abraham, Lourdes Toral‐Barza, James J. Gibbons, Judy Lucas, Arie Zask, Boris Shor, Semiramis Ayral‐Kaloustian, Irwin Hollander, Jeroen C. Verheijen and William Bayona. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.